ALLMedicine™ Amyotrophic Lateral Sclerosis Center
Research & Reviews 15,649 results
https://doi.org/10.1016/j.neurobiolaging.2021.01.007
Neurobiology of Aging; Nunes Gonçalves JP, Leoni TB et. al.
Feb 23rd, 2021 - Many genes associated with familial forms of the amyotrophic lateral sclerosis (fALS) have been identified in European and North American cohorts. However, little is known about the genetic bases of fALS in Latin America and Brazil, in particular....
https://doi.org/10.1080/21678421.2021.1883666
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration; Sun J, Ludvigsson JF et. al.
Feb 23rd, 2021 - Background: Evidence has accumulated to support the involvement of gastrointestinal (GI) dysfunction, possibly via gut microbial dysbiosis and alterations in the enteric nervous system, in the pathophysiology of different neurodegenerative disease...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893595
International Journal of Biological Sciences; Zhang R, Chen Y et. al.
Feb 22nd, 2021 - Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, characterized by phosphorylated TDP-43 (pTDP-43)-positive inclusions in neurons and glial cells. However, the pathogenic mechanism that underlies ALS remains largely u...
https://doi.org/10.1080/00029157.2020.1797623
The American Journal of Clinical Hypnosis; Palmieri A, Kleinbub JR et. al.
Feb 22nd, 2021 - Scarce literature has been dedicated to the psychological treatment of amyotrophic lateral sclerosis (ALS). However, there have been some encouraging findings, such as in hypnosis-based studies, which revealed patient improvements in anxiety, depr...
https://doi.org/10.1016/j.pneurobio.2021.102022
Progress in Neurobiology; Xiao Y, Wang SK et. al.
Feb 22nd, 2021 - Extracellular vesicles (EVs) are heterogeneous cell-derived membranous structures that arise from the endosome system or directly detach from the plasma membrane. In recent years, many advances have been made in the understanding of the clinical d...
Guidelines 9 results
http://aquestive.com/aquestive-therapeutics-receives-fda-approval-for-exservan-riluzole-oral-film/
Nov 24th, 2019 - Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that Exservan™ (riluzole) Oral Film received early-act...
https://doi.org/10.1002/mus.26408
Muscle & Nerve; Pattee GL, Plowman EK et. al.
Jan 8th, 2019 - Universally established comprehensive clinical bulbar scales objectively assessing disease progression in amyotrophic lateral sclerosis (ALS) are currently lacking. The goal of this working group project is to design a best practice set of provisi...
https://www.mda.org/services/neuromuscular-disease-registry
Muscular Dystrophy Association (USA)
Dec 31st, 2015 - In 2013, MDA launched the U. S.
https://doi.org/10.1111/j.1468-1331.2011.03501.x
European Journal of Neurology; , Andersen PM et. al.
Sep 14th, 2011 - The evidence base for the diagnosis and management of amyotrophic lateral sclerosis (ALS) is weak. To provide evidence-based or expert recommendations for the diagnosis and management of ALS based on a literature search and the consensus of an exp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764728
Neurology Miller RG, Jackson CE et. al.
Oct 13th, 2009 - To systematically review evidence bearing on the management of patients with amyotrophic lateral sclerosis (ALS). The authors analyzed studies from 1998 to 2007 to update the 1999 practice parameter. Topics covered in this section include breaking...
Drugs 31 results see all →
Clinicaltrials.gov 16,055 results
https://doi.org/10.1016/j.neurobiolaging.2021.01.007
Neurobiology of Aging; Nunes Gonçalves JP, Leoni TB et. al.
Feb 23rd, 2021 - Many genes associated with familial forms of the amyotrophic lateral sclerosis (fALS) have been identified in European and North American cohorts. However, little is known about the genetic bases of fALS in Latin America and Brazil, in particular....
https://doi.org/10.1080/21678421.2021.1883666
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration; Sun J, Ludvigsson JF et. al.
Feb 23rd, 2021 - Background: Evidence has accumulated to support the involvement of gastrointestinal (GI) dysfunction, possibly via gut microbial dysbiosis and alterations in the enteric nervous system, in the pathophysiology of different neurodegenerative disease...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893595
International Journal of Biological Sciences; Zhang R, Chen Y et. al.
Feb 22nd, 2021 - Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, characterized by phosphorylated TDP-43 (pTDP-43)-positive inclusions in neurons and glial cells. However, the pathogenic mechanism that underlies ALS remains largely u...
https://doi.org/10.1080/00029157.2020.1797623
The American Journal of Clinical Hypnosis; Palmieri A, Kleinbub JR et. al.
Feb 22nd, 2021 - Scarce literature has been dedicated to the psychological treatment of amyotrophic lateral sclerosis (ALS). However, there have been some encouraging findings, such as in hypnosis-based studies, which revealed patient improvements in anxiety, depr...
https://doi.org/10.1016/j.pneurobio.2021.102022
Progress in Neurobiology; Xiao Y, Wang SK et. al.
Feb 22nd, 2021 - Extracellular vesicles (EVs) are heterogeneous cell-derived membranous structures that arise from the endosome system or directly detach from the plasma membrane. In recent years, many advances have been made in the understanding of the clinical d...
News 453 results
https://www.medscape.com/viewarticle/944474
Jan 20th, 2021 - Anita Baron first noticed something was wrong in August 2018, when she began to drool. Her dentist chalked it up to a problem with her jaw. Then her speech became slurred. She managed to keep her company, which offers financing to small businesses...
https://www.staging.medscape.com/viewarticle/938926
Oct 14th, 2020 - NEW YORK (Reuters Health) - Amyotrophic lateral sclerosis (ALS) patients prescribed edaravone are hospitalized more frequently, a new surveillance study in U.S. military veterans shows. Patients on edaravone had significantly higher rates of all-c...
https://www.medscape.com/viewarticle/938926
Oct 14th, 2020 - NEW YORK (Reuters Health) - Amyotrophic lateral sclerosis (ALS) patients prescribed edaravone are hospitalized more frequently, a new surveillance study in U.S. military veterans shows. Patients on edaravone had significantly higher rates of all-c...
https://www.staging.medscape.com/viewarticle/936885
Sep 2nd, 2020 - Treatment with a fixed-dose combination of sodium phenylbutyrate and taurursodiol (AMX0035, Amylyx Pharmaceuticals) slows the rate of decline in physical function in patients with amyotrophic lateral sclerosis (ALS), according to results of the ph...
https://www.medscape.com/viewarticle/936885
Sep 2nd, 2020 - Treatment with a fixed-dose combination of sodium phenylbutyrate and taurursodiol (AMX0035, Amylyx Pharmaceuticals) slows the rate of decline in physical function in patients with amyotrophic lateral sclerosis (ALS), according to results of the ph...